Peter H. Odonnell

Peter Odonnell practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Peter Odonnell's NPI, 1861695819, was assigned on June 7, 2007. Peter Odonnell graduated from University of Chicago, Pritzker School of Medicine in 2003.

Peter Odonnell's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Peter Odonnell's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Peter Odonnell is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Peter Odonnell to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Peter Odonnell practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Peter Odonnell's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Peter Odonnell has a license on file in Illinois.

CMS data shows 200 Medicare services from Peter Odonnell across 6 procedure codes in 2024, for 98 Medicare patients. Medicare paid $20,660 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Peter Odonnell in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Peter Odonnell's median patient age at 73, with 41% women.

In 2024, Peter Odonnell wrote 62 Medicare Part D claims for 15 patients. 76% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $170,254 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Peter Odonnell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Peter Odonnell to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Transitional Cell and Urinary Bladder Neoplasms. Open Payments lists research payments to Peter Odonnell that name 1 trial.

CMS Open Payments shows 242 general payments to Peter Odonnell from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Merck Sharp & Dohme Corporation paid the most, $103,020. It also lists 19 research payments totaling $11,798 from 2021 to 2025, naming 1 clinical trial.

Peter Odonnell graduated from University of Chicago, Pritzker School of Medicine in 2003.